ClinicalTrials.gov
ClinicalTrials.gov Menu

Transfusion Reaction by Washed Red Blood Cell (RBC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01934907
Recruitment Status : Completed
First Posted : September 4, 2013
Last Update Posted : October 11, 2017
Sponsor:
Information provided by (Responsible Party):
Hyo-Seok Na, Seoul National University Bundang Hospital

Brief Summary:
The hypothesis is that transfusion of washed red blood cell can decrease the complication by transfusion.

Condition or disease Intervention/treatment Phase
Orthopedic Disorder Other: Washing of packed RBC by normal saline Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 9 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Actual Study Start Date : August 2013
Actual Primary Completion Date : August 2016
Actual Study Completion Date : August 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: washed RBC
Packed RBCs are Washed and then, transfused.
Other: Washing of packed RBC by normal saline
No Intervention: pack RBC
Packed RBCs are transfused.



Primary Outcome Measures :
  1. Complication by transfusion [ Time Frame: Operation day and during postoperative 5 days ]

Secondary Outcome Measures :
  1. Total units of RBC transfused. [ Time Frame: On the operation day and during the postoperative 5 days ]
  2. Hemoglobin [ Time Frame: 1 day before the operation day and postoperative 1 day ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergoing total hip replacement arthroplasty

Exclusion Criteria:

  • Patients who do not agree with this clinical study.
  • Patients who have a history of transfusion for recent 1 month.
  • Patients who have rare blood types.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01934907


Locations
Korea, Republic of
Seoul National University Bundang Hospital
Seongnam, Gyeonggi, Korea, Republic of, 443-607
Sponsors and Collaborators
Seoul National University Bundang Hospital

Responsible Party: Hyo-Seok Na, Dr., Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier: NCT01934907     History of Changes
Other Study ID Numbers: B-1307/212-009
First Posted: September 4, 2013    Key Record Dates
Last Update Posted: October 11, 2017
Last Verified: October 2017

Additional relevant MeSH terms:
Musculoskeletal Diseases